IIR 03-267
Reinforcement of Abstinence and Attendance in Substance Abuse Treatment
Steven J Lash, PhD Salem VA Medical Center, Salem, VA Salem, VA Funding Period: August 2006 - March 2010 Portfolio Assignment: Mental and Behavioral Health |
BACKGROUND/RATIONALE:
Although substance use disorder (SUD) treatment continuing care participation is strongly related to positive outcomes, participation rates are low and few effective adherence interventions have been developed. OBJECTIVE(S): This multi-site randomized clinical trial hypothesized that an enhanced version of Contracts, Prompts and Reinforcement (CPR+) compared to standard treatment (STX) would: 1) increase continuing care adherence, 2) increase 1-year abstinence rates, 3) demonstrate cost-effectiveness, 4) generalize across VA sites and 5) be particularly effective with participants with co-occurring psychiatric disorders. METHODS: Participants (n = 183) from the Salem and Jackson VAMCs were blocked on SUD diagnosis, presence of a co-occurring psychiatric disorder, and selected aftercare therapy group time prior to randomization to STX or CPR+ at each site. Participants were primarily African-American (54%) and Caucasian (44%) male (96%) veterans. Co-occurring psychiatric disorders were present in 62% of the sample, and 33% were alcohol dependent only while 67% were drug dependent. Treatment outcome was measured 3-, 6-, and 12-months after participants entered treatment. Abstinence rates were analyzed using a longitudinal logistic GEE (Generalized Estimating Equations) regression model. Secondary outcomes were analyzed using both logistic and linear mixed-effects models as appropriate. FINDINGS/RESULTS: We enrolled 102% of the projected number of participants and the follow-up rates were high. Among CPR+ participants,70% received at least 4 months of treatment compared to 58% of the STX group (p = .06). There was no significant change in the aftercare participation rate between groups over time during the 12 months of follow-up (p = .36). The average monthly rate (two or more sessions) was 51% for CPR+ and 44% for STX. Furthermore, the increase in the frequency of support group participation over 1 year was not significant (54.6 vs. 45.7; p = .17). Additionally, the CPR+ participants were not more likely than the STX group to be abstinent at the 3-month (67% vs. 71%; p =.52), 6-month (52% vs. 51%; p = .87), or 12-month interviews (48% vs. 49%; p = .68). The capital and labor cost of conducting CPR+ for one year was $266.54 per participant. The incremental cost compared to STX was $98.25 per participant. Data suggests that CPR+ was effective for individuals not required to attend continuing care. The effects of CPR+ were not moderated by site, co-occurring psychiatric disorder, or substance of abuse. IMPACT: The current trial demonstrated that CPR+ could be implemented at new VAMC sites, but it did not replicate the positive effects observed in previous trials. CPR+ did not significantly improve continuing care attendance, substance use outcomes, or quality of life compared to the STX group. A much higher percentage of participants in this trial compared to previous trials were required to attend aftercare. Results suggest that CPR+ was ineffective for those require to attend aftercare, but effective for those without this source of motivation. Additionally, findings suggest that changes to improve and adapt CPR+ to sites may have lessened its effectiveness in this trial. External Links for this ProjectDimensions for VADimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.Learn more about Dimensions for VA. VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address. Search Dimensions for this project PUBLICATIONS:Journal Articles
DRA:
Substance Use Disorders
DRE: none Keywords: Addictive Disorders MeSH Terms: none |